StockData
Arvinas, Inc. logo

Arvinas, Inc. (ARVN) stock

ARVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$6.76−0.06 (-0.81%)

Close on Nov 18, 2026Market cap $442.34MP/E 42.3Yield –

Arvinas revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Arvinas's revenue for the twelve months ending Jun 30, 2026 was $316.70M, down 15.0% year over year. For fiscal 2025 it was $262.60M, down 0.3% from the year before. The highest annual figure on record is $263.40M in fiscal 2024.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$262.60M-0.3%
FY2024Dec 31, 2024$263.40M+235.5%
FY2023Dec 31, 2023$78.50M-40.3%
FY2022Dec 31, 2022$131.40M+145.1%
FY2021Dec 31, 2021$53.60M+106.9%
FY2020Dec 31, 2020$25.90M-39.8%
FY2019Dec 31, 2019$43.00M+200.2%
FY2018Dec 31, 2018$14.32M+89.0%
FY2017Dec 31, 2017$7.58M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$249.70M+1014.7%
Q1 FY2026Mar 31, 2026$15.60M-91.7%
Q4 FY2025Dec 31, 2025$9.50M-84.0%
Q3 FY2025Sep 30, 2025$41.90M-59.1%
Q2 FY2025Jun 30, 2025$22.40M-70.7%
Q1 FY2025Mar 31, 2025$188.80M+646.2%
Q4 FY2024Dec 31, 2024$59.20M+71.1%
Q3 FY2024Sep 30, 2024$102.40M+87.9%
Q2 FY2024Jun 30, 2024$76.50M+135.4%
Q1 FY2024Mar 31, 2024$25.30M-33.1%
Q3 FY2023Sep 30, 2023$34.60M+4.2%
Q2 FY2023Jun 30, 2023$54.50M+61.2%
Q1 FY2023Mar 31, 2023$32.50M+22.6%
Q4 FY2022Dec 31, 2022$37.80M+13.9%
Q3 FY2022Sep 30, 2022$33.20M+257.0%
Q2 FY2022Jun 30, 2022$33.80M+514.5%
Q1 FY2022Mar 31, 2022$26.50M+381.8%
Q4 FY2021Dec 31, 2021$33.20M+425.7%
Q3 FY2021Sep 30, 2021$9.30M+22.4%
Q2 FY2021Jun 30, 2021$5.50M-4.3%
Q1 FY2021Mar 31, 2021$5.50M-11.9%
Q4 FY2020Dec 31, 2020$6.32M+29.1%
Q3 FY2020Sep 30, 2020$7.60M-74.7%
Q2 FY2020Jun 30, 2020$5.75M+43.1%
Q1 FY2020Mar 31, 2020$6.24M+55.4%
Q4 FY2019Dec 31, 2019$4.89M+42.2%
Q3 FY2019Sep 30, 2019$30.05M+790.3%
Q2 FY2019Jun 30, 2019$4.02M+18.1%
Q1 FY2019Mar 31, 2019$4.02M-2.2%
Q4 FY2018Dec 31, 2018$3.44M+33.7%
Q3 FY2018Sep 30, 2018$3.38M+102.2%
Q2 FY2018Jun 30, 2018$3.40M+103.7%
Q1 FY2018Mar 31, 2018$4.11M+146.2%
Q4 FY2017Dec 31, 2017$2.57M–
Q3 FY2017Sep 30, 2017$1.67M–
Q2 FY2017Jun 30, 2017$1.67M–
Q1 FY2017Mar 31, 2017$1.67M–

More Arvinas figures

See a number that looks wrong?